Cargando…

Infectious complications of immune checkpoint inhibitors in solid organ malignancies

BACKGROUND: Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on their infectious complications. The objective is to describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Justine Abella, Komoda, Kellie, Pal, Sumanta, Dickter, Jana, Salgia, Ravi, Dadwal, Sanjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704147/
https://www.ncbi.nlm.nih.gov/pubmed/34873868
http://dx.doi.org/10.1002/cam4.4393